PortViewPortView
TRUH logo

VanEck Healthcare TruSector (TRUH) ETF Holdings & Analysis

ETFOther

$30.20+0.93%
1-year price historyRange $24.90 – $30.62
52-week range$30.20
$24.78$30.62

What TRUH does

The VanEck Healthcare TruSector ETF (TRUH) is an actively managed investment vehicle designed to generate substantial capital growth over an extended period. It achieves this by strategically allocating capital to businesses operating within the healthcare industry, whether directly through their securities or via other financial instruments that offer exposure to the sector.

Fund profile

Category
Other
AUM
$565,525
Holdings
10
52-week high
$30.62
52-week low
$24.78

Top holdings

Top 1061%
HoldingWeight
Eli Lilly & Co14.97%
Johnson & Johnson10.41%
Abbvie Inc7.37%
Merck & Co Inc5.94%
Unitedhealth Group Inc5.76%
Amgen Inc3.76%
Thermo Fisher Scientific Inc3.73%
Abbott Laboratories3.13%
Gilead Sciences Inc2.98%
Pfizer Inc2.65%

Geographic allocation

United States98.02%
Ireland1.91%
Other0.08%

PortView Portfolio Insights

PortView analyzes how TRUH fits your actual portfolio — position weight, ETF overlap with your other funds, sector and geographic exposure, concentration, and how this fund contributes to your portfolio risk and return. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze TRUH in PortView →

Related securities

Related stocks

Frequently asked questions

What does TRUH track?
TRUH is the VanEck Healthcare TruSector ETF, a Other ETF.
What is the expense ratio of TRUH?
Expense ratio data for TRUH is shown on the page when available from our data provider.
What are the largest holdings in TRUH?
Top holdings include LLY, JNJ, ABBV, MRK, UNH.
How can PortView analyze TRUH overlap with other ETFs?
PortView computes the holdings overlap between TRUH and the other ETFs and stocks you own, plus your combined sector and geographic exposure, so you can see true diversification.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.